Orally active α
-glucosidase I and II and ceramide-specific glycosyltransferase inhibitor. Rescues trafficking-deficient F508del-CFTR in human airway epithelial cells via inhibition of ER α
-glucosidases I and II. Also has broad spectrum antiviral activity.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Other Product-Specific Information:
N-Butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis.
Platt et al.
Targeting glycosylation as a therapeutic approach.
Dwek et al.
Nat.Rev.Drug Disc., 2002;1:65
The citations listed below are publications that use Tocris products. Selected citations for Miglustat hydrochloride include:
Showing Results 1 - 1 of 1